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PNA-Encoded Protease Substrate Microarrays
peutic targets, and monitoring their activity can be diag-Nicolas Winssinger,1,* Robert Damoiseaux,2
David C. Tully,2 Bernhard H. Geierstanger,2 nostic and prognostic of disease states.
A major characteristic of a given protease is its sub-Keith Burdick, and Jennifer L. Harris2,3,*
1Institut de Science et d’Inge´nierie strate specificity that can range from very broad—as for
proteases involved in catabolism—to very narrow—asSupramole´culaires
Universite´ Louis Pasteur for proteases involved in the regulation of cellular
events. Historically, the substrate specificity of a prote-8 alle´e Guaspard Monge
67000 Strasbourg ase was determined through the identification of cleav-
age sites in macromolecular substrates or through theFrance
2 Genomics Institute of the Novartis Research screening of individually synthesized peptide substrates
[3, 4]. However, these methods do not allow for theFoundation
10675 John Jay Hopkins Drive complete screening of the substrate specificity of a pro-
tease because not all combinations of protein substrateSan Diego, California 92121
3 Department of Molecular Biology sequences can be considered in these experiments.
Several combinatorial peptide synthesis techniquesThe Scripps Research Institute
10550 North Torrey Pines Road have been employed to identify the substrate specificity
of proteases. These techniques include solution screen-La Jolla, California 92037
ing methods, such as positional scanning substrate li-
braries [5–7], and solid support screening methods,
such as bead-based fluorescence resonance energySummary
transfer (FRET) peptide libraries [8] and peptide microar-
rays [9, 10]. The advantage of screening substrates inOur current understanding of the role and regulation
solution is that the interaction between protease andof protease activity in normal and pathogenic pro-
substrate is generally more physiological in nature andcesses is limited by our ability to measure and decon-
avoids nonspecific interactions that can arise with solidvolute their enzymatic activity. To address this limi-
support screening strategies [11]. Here, we describetation, an approach was developed that utilizes
a method for determining the substrate specificity ofrhodamine-based fluorogenic substrates encoded
proteases through the solution-based screening of pep-with PNA tags. The PNA tags address each of the
tide substrate libraries and microarray detection of thesubstrates to a predefined location on an oligonucleo-
cleavage products.tide microarray through hybridization, thus allowing
the deconvolution of multiple signals from a solution.
A library of 192 protease substrates was prepared by
Results and Discussion
split and mix combinatorial synthesis. The methodol-
ogy and validation of this approach for profiling pro-
We have previously described the use of microarray-
teolytic activity from single proteases and from those
based technology to measure protease activity based
in crude cell lysates as well as clinical blood samples
on the selective labeling of proteases by using suicide
is described.
inhibitors tethered to PNA tags [12, 13]. The inhibitors
that have not reacted with a protease are removed by
Introduction size exclusion filtration, and the remaining inhibitors are
hybridized to an oligonucleotide array for detection.
The precise and limited action of proteases is a mecha- Herein, we report an alternative and complementary ap-
nism by which cells regulate many vital events. Prote- proach that utilizes fluorogenic protease substrates
ases themselves are nearly exclusively regulated by linked to PNA. As shown in Figure 1A, proteolysis of the
posttranslational modifications. There are over 500 pu- bond connecting the substrate to the latent fluorophore
tative human proteases [1], and a number of these are changes the electronic properties of this fluorophore,
involved in the regulation of essential cellular processes resulting in a large increase in fluorescence. An advan-
such as DNA replication, cell cycle progression, differen- tage of latent fluorogenic substrates over substrates
tiation, migration, morphogenesis, immunity, hemosta- linking FRET fluorophores is that only proteolysis at the
sis, neuronal outgrowth, and apoptosis. Misregulation residue adjacent to the fluorophore gives a signal. This
of proteolytic activity is involved in many pathological property allows for the register of amino acids in the
situations like neurodegeneration, cardiovascular dis- substrate sequence relative to the cleavage site to be
eases, arthritis, cancer, and infectious diseases [2]. Fur- clearly defined. Rhodamine exhibits several unique
thermore, a number of pathogens require the activity properties that make it particularly well suited for this
of an endogenous or host protease in their infection/ microarray application. First, the latent fluorophore is
replication cycle. Proteases are thus attractive thera- 1000-fold less fluorescent than its hydrolyzed counter-
part [14] (Figure 1A). Second, rhodamine possesses an
absorption/emission spectrum, which allows for the use*Correspondence: winssinger@isis-ulp.org (N.W.); harris@scripps.
edu (J.L.H.) of an argon-ion laser, a common excitation source in
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Figure 1. PNA-Encoded Fluorogenic Substrate Libraries
(A) Structure of rhodamine as a latent acylated fluorophore (left) and its fluorescent counterpart (right).
(B) Profiling with the PNA-encoded rhodamine-substrate library.
laboratory instrumentation. Third, the fluorescence of good substrates for the serine protease thrombin and
the cysteine protease caspase-3, respectively [7, 17].rhodamine is largely independent of the pH, allowing
for the adjustment of the pH to the needs of a wide Both substrate pairs were efficiently hydrolyzed only by
their cognate enzymes. The Michaelis-Menten parame-range of conditions. Last but not least, small peptides
on the rhodamine have been shown to be accepted as ters of the PNA-tagged substrate were comparable to
the substrates lacking the PNA tag (Table 1). This findingsubstrates by serine and cysteine proteases [14–16].
It is recognized, however, that aspartyl- and metallo- is in agreement with our previous observation that the
PNA does not interfere with the inhibitory activity ofproteinases and some serine and cysteine proteases
will require prime-side interactions with the substrate tethered molecules [18].
PNAs are particularly well suited for hybridization tofor productive hydrolysis and may not be detected with
these fluorogenic substrates. a DNA chip since the DNA-PNA interaction is stronger
than a corresponding DNA-DNA interaction [19]. SingleProteolysis is measured by incubating the PNA-
encoded library of substrates with the sample of interest base pair mismatchs thus have a more pronounced de-
stabilization on a PNA-DNA duplex than on a DNA-DNA(Figure 1B). The fluorescence signal from the library is
resolved by hybridization to an oligonucleotide microar- duplex. Furthermore, the PNA-encoding strategy is ideal
for the library synthesis, as it allows for the rapid genera-ray. The location of hybridization is dictated by the se-
quence of the PNA, which is linked to the sequence of tion of libraries by split and mix synthesis [20]. This
strategy requires the use of orthogonal protectingthe substrate peptide. The general structure of the li-
brary is shown in Figure 2. Compared to the use of the groups for the cosynthesis of the peptide and PNA
chains. The library synthesized herein relied on the alter-suicide inhibitor library previously reported, the fluoro-
genic substrate strategy has the potential of being more nating use of Fmoc-protected PNA monomers (13, Fig-
ure 4) and Alloc-protected amino acids (14, Figuresensitive since one protease can turn over many sub-
strates, thus leading to signal amplification. While mi- 4) [21].
To evaluate selectivity and quantification of enzymaticcroarrays of fluorogenic substrates generated by print-
ing substrates directly on a solid surface have been activity using PNA-encoded substrates, an equimolar
mixture of 9 and 12 was hybridized to Affymetrix GenFlexreported [9], the PNA-encoding system has the advan-
tage of allowing proteolysis to be carried out in solution. chips (Figure 5A) at concentrations ranging from 10 pM
to 800 pM prior to and after treatment with caspase-3.This is important in order to exclude the effects of non-
specific interactions of the enzymes with the surface and Only the feature on the chip corresponding to caspase-3
showed a strong linear signal increase (Figure 5).offers better control of substrate/analyte concentration
and reaction conditions. Our next goal was to prepare a PNA-encoded rhoda-
mine substrate library. A 192 member tetrapeptide li-To evaluate the effect of a PNA tag on substrate hydro-
lysis, two pairs of rhodamine peptide substrates with brary consisting of three different amino acids in the P1
and four different amino acids in the P2–P4 positionsand without the PNA tag were synthesized (8 versus 9
and 11 versus 12, Figure 3). The sequences nTPR (N to was prepared as shown in Figure 4. Each tetrapeptide
was encoded by a 14-mer PNA using four codon sets,C terminus, n represents norleucine) and DEVD were
selected based on the fact that they are known to be as shown in Figure 2. The sequences of the codons
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1353
Figure 2. General Structure of the 192 Member PNA-Encoded Rhodamine Substrate Library
represent a subset of the previously described codon ing temperatures. The specific codons of this subset
were selected based on empirical observation of theset [12] and were chosen to balance two primary design
goals, fidelity of hybridization and homogeneity of melt- hybridization properties.
Figure 3. Synthesis of Caspase and Throm-




Table 1. Comparison of Km, kcat, and kcat/Km of Rhodamine Protease Substrates with and without PNA Tag for Both Caspase-3
and Thrombin
Substrate KM kcat kcat/KM
Caspase-3
(DEVD)2-Rh-Ac (8) 26 M 0.083 s1 3.2  103 M1 s1
(DEVD)2-Rh-PNA (9) 9.4 M 0.032 s1 3.2  103 M1 s1
Thrombin
(nTPR)2-Rh-Ac (11) 71 M 1.67 s1 2.3  102 M1 s1
(nTPR)2-Rh-PNA (12) 247 M 4.40 s1 1.8  102 M1 s1
We tested our PNA-encoded library by limited proteol- demonstrate that it is possible to use the PNA-encoded
fluorogenic substrates for screening proteolytic activi-ysis with thrombin, plasmin, or caspase-3. The product
of this proteolysis was then hybridized to an oligonucle- ties in complex biological samples.
An important asset of this technology is its miniatur-otide microarray, and the fluorescence intensity corre-
sponding to each probe was measured (Figures 6A–6C). ization, having the ability to measure the activity of hun-
dreds of substrates in only a few microliters. This mayThe observed substrate specificity was indeed consis-
tent with the known specificity for each enzyme. As prove important in the profiling of proteolytic activity in
clinical samples. Comparative activity profiling shouldexpected, caspase-3 showed a strong preference for
substrates with P1  Asp, P2  Val, and P4  Asp, allow for a better understanding of protease activity
involved in healthy and pathological processes or drugwith DTVD as the optimal substrate. While thrombin and
plasmin showed the same strong preference for P1 and action. To evaluate the potential of PNA-encoded librar-
ies toward diagnostic applications, the coagulation cas-P4 residues (Arg and Nle), plasmin was selective for P2
Phe and had some preference for P3  Thr, whereas cade in clinical blood samples appeared to be a relevant
example. The activity profile of blood samples fromthrombin showed a high specificity for P2  Pro and
broad specificity for P3. healthy donors was compared to blood samples from
an individual treated with warfarin, a frequently usedHaving established the use of the PNA-encoded sub-
strate library to profile protease specificity, we turned drug for oral anticoagulant therapy. Warfarin decreases
the level of active prothrombin, factor X, factor IX, factorour attention to its use in profiling protease activity in
complex mixtures such as crude cell lysates. To this VII, and protein C by blocking their vitamin K-dependent
carboxylation of glutamic acid moieties that is essentialend, we opted to compare profiles of protease activity
from apoptotic cell lysates versus nonapoptotic cell ly- for their synthesis and function [24]. The samples from
the patient treated with warfarin were characterized assates. It is important to note that apoptosis does not
manifest itself as an enhanced expression of caspase-3 having an international normalized ratio (INR) of 5.0. The
INR is the ratio of the coagulation time of a given samplebut rather as an increase in enzymatic activity, which is
due to a proteolytic conversion of the caspase-3 zymo- divided by the coagulation time of a blood sample from
a healthy donor. The samples were incubated with thegen. Changes in proteolytic activities that are based on
posttranslational modification can not be monitored by PNA-encoded library and hybridized to the oligonucleo-
tide arrays. Proteolytic activity was only observed forprotein expression profiling experiments, emphasizing
the importance of measuring protein function rather than substrates containing P1 R. The normal blood sample
shows a profile in P1R, P2P (Figure 7) that is similarmRNA message or protein levels [22, 23]. The PNA-
encoded substrate library was treated either with apo- to thrombin (Figure 6A), a major proteolytic activity in
the coagulation cascade. From these data, it is clearptotic or nonapoptotic cell lysate and was hybridized
to the oligonucleotide arrays. The profile of the nonapo- that warfarin treatment largely abolishes the thrombin-
mediated signal transduction within the coagulationptotic lysate was then subtracted from the apoptotic
lysate, resulting in the difference profile. The most in- cascade, leading to inhibition of coagulation (Figure 7).
tense signals observed in the difference profile are found
in P1Asp, P2 Val, and P4Asp, with DTVD showing Significance
the most activity. This activity matches the specificity
fingerprint of caspase-3, clearly indicating the activation Proteases play a crucial role in regulating numerous
cellular events. The ability to measure their activityof this protease in the apoptotic crude cell lysate (Figure
6D). While less intense than the caspase-3 fingerprint, on a proteomic scale and correlate such activity to
phenotypes of interest would facilitate the under-other prominent activities are found for P1  Arg and
P2  Val, indicating an increase in the activity of addi- standing of their cellular function and may prove to
be a sensitive diagnostic tool. Toward these goals,tional protease(s) (Figure 6D). The test library of 192
substrates only represents a small fraction of the we have developed a method based on PNA-encoded
libraries of fluorogenic substrates to profile protease160,000 possible (204) tetrapeptide sequences, and
while caspase-3 activity is clearly measurable, addi- specificity in a microarray format. We have shown that
such a library can be used to quantify protease activitytional proteolytic activities may also be present that
cannot be monitored with the limited set of substrates and substrate specificity of both serine and cysteine
proteases in minimal volumes. More significantly, werepresented in this test library. Nevertheless, the results
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Figure 4. Synthesis of the PNA-Encoded Library
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Figure 5. Proteolysis of Test Substrates
(A and B) The complementary oligonucleotide
features on an Affymetrix microarray are
shown for the caspase-3 and thrombin
probes 9 and 12, respectively. When cas-
pase-3 is incubated with both probes and
then hybridized on the microarray, only the
caspase-3 feature shows appreciable fluo-
rescence with a linear relationship to the con-
centration of the substrate shown in (B). The
data shown are from a single representative
microarray experiment.
et al. [25]. If not stated otherwise, all solid support reactions weredemonstrated that the method can be used with com-
carried out under an inert atmosphere in an Argonaut Quest 210plex mixtures such as crude cell lysates and clinical
Organic Synthesizer.blood samples. Expansion of this technology to larger
substrate libraries should allow for even greater versa-
Synthesis of TFA-Rhodamine-NHS Ester 4
tility in the characterization of proteolytic activity with 3-Aminophenol (10.0 g, 0.091 mol, 3.3 eq) was dissolved in H2SO4
potential applications as a diagnostic tool. The re- (65.0 ml, 95%–97%), and 1,2,4-benzenetricarboxilic acid (5.76 g,
0.027 mol, 1.0 eq) was added [26]. The reaction mixture was warmedported technology should prove valuable in gaining a
to 180C and kept at this temperature for 6 hr. After cooling to roombetter understanding of complex proteolytic events
temperature, the reaction mixture was poured onto 70 g ice andinvolved in the regulation of cellular processes and
stirred. The sulfuric acid was neutralized with solid sodium carbon-the pathogenesis of disease. Finally, this report further
ate, and MeOH (300 ml) was added to precipitate the inorganic salts
expands the scope and applications of PNA-encoded that were removed by filtration. The filter cake was washed with
libraries and their conversion into a spatially ad- MeOH (200 ml), and the methanolic solutions were combined. After
removal of the solvents, the residues were dissolved in methanoldressable microarray.
and adsorbed onto silica (30 g). This dry pack product was purified
by flash chromatography on silica (200 g) with a step gradient ofExperimental Procedures
acetonitrile/MeOH (7:3) to acetonitrile/MeOH/H2O/Et3N (20:5:4:1).
Evaporation of the solvents under reduced pressure yielded 6.5 gAll peptide synthesis reagents and resins were purchased from No-
vabiochem. PNA monomers as well as HATU were purchased from of a mixture of 3,6-Di-amino-spiro[phtalan-1,9-xanthene]-5-car-
boxylic acid and 3,6-Di-amino-spiro[phtalan-1,9-xanthene]-6-car-Applied Biosystem, and other chemicals were purchased from Ald-
rich. Thrombin was purchased from Haematologic Technologies. boxylic acid (0.17 mol, 63%) as dark red crystalline solid. LC/MS
characterization indicated about 90% purity. An analytical samplePlasma samples, pooled normal plasma (catalog number 0010), and
the multi-coumadin set (catalog number 9400) were purchased from was obtained by recrystallization from acetone/water with a product
purity 98%.George King Biomedicals Inc., and activated partial thromboplastin
reagents were purchased from Biome´rieux and used as recom- The purified (90% purity level) 3,6-di-amino-spiro[phtalan-1,9-
xanthene]-5-carboxylic/6-carboxylic acid (188 mg, 0.5 mmol, 1.0 eq,mended by the manufacturer. Caspase-3 was recombinantly ex-
pressed and purified by similar methods to those described by Zhou coevaporated three times with dry pyridine) was suspended in dry
PNA-Encoded Small-Molecule Probes
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Figure 7. Proteolytic Activity of Plasma from a Normal Individual
and an Individual on Warfarin Therapy
Only P1  R is shown as P1  L, and P1  D did not show any
significant activity. Treatment with warfarin leads to a dramatic re-
duction of thrombin proteolytic activity, thereby inhibiting the signal
transduction cascade leading to coagulation. The mean of six exper-
iments is represented.
pyridine (4 ml), and trifluoroacetic acid anhydride (190 l, 1.3 mmol,
2.6 eq) was added dropwise. The reaction mixture was stirred over-
night, and the solvents were removed under reduced pressure. The
residue was dissolved in 2 ml CH2Cl2, and 403 mg N-hydroxysuccini-
mide (3.5 mmol, 7.0 eq) and 477 mg 1-ethyl-3-(3-dimethylaminopro-
pyl)carbodiimide hydrochloride (2.5 mmol, 5.0 eq) were added. The
reaction mixture was stirred for 35 min, then diluted with CH2Cl2
(100 m) and washed with H2O (100 ml). The organic phase was
dried with sodium sulfate, filtered, and concentrated under reduced
pressure. Flash chromatography on silica gel (20 g) with a step
gradient of hexane/ethyl (3:1 to 1:1) afforded the desired TFA-rhoda-
mine-NHS ester 4 [27] (46 mg, 0.07 mmol, 14% over 2 steps).
Synthesis of the Rhodamine Resin 6
Rink amide resin (0.7 mmol/g) was loaded with orthogonally pro-
tected Fmoc-Lys(Mtt)-OH to a fixed loading of 0.4 mmol/g then
capped with Ac2O (5.0 eq) and 2,6-lut. (5.0 eq). A portion of this
resin (900 mg, 0.36 mmol) was selectively Fmoc deprotected at the
 terminus (20% piperidine in DMF), washed, and coupled to the
Figure 6. Fluorescence Intensities of the 192 Member PNA-
rhodamine 4 (750 mg, 1.13 mmol, 3.1 eq) in the presence of HOBt
Encoded Substrate Library after Incubation with Different Proteases
(178 mg, 1.31 mmol, 3.1 eq) and iPr2EtN (196 l, 1.13 mmol, 3.1 eq)
(A–C) Map of the spatial deconvolution signals of the 192 member in DMF (4.5 ml) for 12 hr to obtain resin 5. The completion of the
PNA-encoded substrate library after incubation with (A) thrombin, reaction was verified by LC/MS analysis of the cleavage of a resin
(B) plasmin, or (C) caspase-3. aliquot. The trifluoroacetyl protecting groups of the rhodamine were
(D) Difference profile derived by subtracting the fluorescence inten- removed by treatment with concentrated aqueous ammonia (10 ml)
sity values of the nonapoptotic cell lysate from the apoptotic cell for 4 hr to obtain polymer bound rhodamine 6.
lysate. The activation of caspase-3 during apoptosis can be moni-
tored by comparison of the signals on the P1  aspartic acid subar- Synthesis of Single Substrates 7–12
ray of the purified enzyme with the differential signal from the two Two batches of rhodamine resin 6 (250 mg suspended in 1 ml in
lysates. The data shown represent the normalized mean from six DMF) were coupled with Fmoc-Asp(O-t-Bu)-OH or Fmoc-Arg(Pbf)-
experiments, with green representing the minimum fluorescence OH, respectively, using 4.0 eq of amino acid preactivated with HATU
and red representing the maximum fluorescence. (3.5 eq), iPr2EtN (4.0 eq), and lutidine (6.0 eq) in 1 ml DMF. The
couplings were carried out for 12 hr and were repeated twice. Analy-
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sis of the cleavage of a resin aliquot by LC/MS indicated a coupling initiated by the addition of 50 l of the buffer containing the enzyme
at a concentration of 1 nM for thrombin or 20 nM for caspase-3.yield of 86% for the Fmoc-Asp(O-t-Bu) and 61% for the Fmoc-
Arg(Pbf). These yields were confirmed by Fmoc quantification. Any The hydrolysis of rhodamine substrates was measured with a Spec-
tramax Gemini XS spectrofluorimeter (Molecular Devices) thermo-remaining free rhodamine amino functions were acetylated over-
night with acetic acid, DIC, and 3-nitrotriazole (1 M each in DMF, stated at 37C with an excitation wavelength of 490 nm, an emission
wavelength of 530 nm, and a cutoff wavelength of 515 nm.12 ml). The completion of the acetylation was verified by LC/MS
analysis of the cleavage of a resin aliquot. Standard Fmoc deprotec-
tion (20% piperidine in DMF for 5 min) and amino acid coupling Single Substrate Kinetics
(HOBt, DIC, 5 eq each) were used for the subsequent coupling to Thrombin was used at a final concentration of 1.25 nM, and cas-
yield (nTPR)2-rhodamine and (DEVD)2-rhodamine (where n repre- pase-3 was used at a final concentration of 50 nM. The final concen-
sents norleucine). The overall coupling yields for the three couplings tration of the substrates ranged from 1 M to 150 M; the final
were 90%, as determined by Fmoc analysis. The N-terminal Fmoc concentration of DMF in the assay was less than 5%. A total of 10
was removed, and the peptide was capped with an acetate (AcOH, l of the buffer containing the substrate was transferred into a well
DIC, HOBt, 5 eq each). The Mtt was removed under mild acidic of a black 384-well plate with a clear bottom (Corning). The reaction
conditions (CH2Cl2, TFA, and TIS at 94:1:5, 2 ml, 4  2 min), and the was initiated by the addition of 10 l of buffer containing the enzyme
resulting amine was free based by washing the resin with a 1% at a concentration of 2.5 nM for thrombin or 100 nM for caspase-3
solution of iPr2EtN in CH2Cl2 to obtain polymer bound compound 7 and was monitored by fluorescence as described above.
and 10. A portion of each resin was acetylated and cleaved (TFA,
water, and TIS, 95: 2.5: 2.5, 2 hr) to afford, after pelleting in Et2O,
Determination of the Substrate Concentrationcompound 8 and 11. The structure of these two compounds was
by Using Total Hydrolysisverified by mass spectroscopy (MALDI-TOF, 1543.6 calcd for 7,
Serial dilutions of the substrates were performed in the correspond-found: 1544.1 [M	H]	, 1567.3 [M	Na]	; 1561.8 calcd for 10, found:
ing buffers, and thrombin or caspase-3 was added to a final concen-1562.9[M	H]	). A portion of polymer bound compound 7 and 10
tration of 5 nM or 100 nM, respectively. The mixture was incubated(10 mg) were inserted into a DNA synthesis cartridge and placed
overnight at room temperature. The endpoint fluorescence wason an Applied Biosystems Expedite 8909 PNA synthesizer. The PNA
measured as described above. The concentration of the rhodaminesequence was programmed and carried out according to the manu-
substrate for each dilution was determined by comparison of itsfacturer’s recommendations. Cleavage of the resulting resin with
fluorescence with the fluorescence of solutions containing knownTFA:m-cresol (4:1, 300 l), followed by pelleting in Et2O, afforded
amounts of the rhodamine in the same buffer system.PNA-encoded compound 9 and 12. Again, the structure of these
Total hydrolysis of the 192 member library was performed in THBtwo compounds was verified by mass spectroscopy (MALDI-TOF,
by sequential treatment with the following proteases: protease from5596.4 calcd for 9, found: 5595.5 [M	H]	, 1567.3 [M	Na]	;
Streptomycis Griseus, subtilisin Carlsbad and trypsin from bovine5553.7calcd for 12, found: 5553.3 [M	H]	). Compounds 8, 9, 11,
pancreas. Total hydrolysis was confirmed by MALDI-TOF analysis.and 12 were dissolved into H2O:MeCN (9:1), frozen, lyophilized, and
The total concentration of the rhodamine library was determined byused for subsequent experiments without further purifications.
fluorescence measurement as described above.
Synthesis of the 192 Member PNA-Encoded
Spatial Deconvolution of Single Protease ProbesProtease Substrate Library
on Affymetrix ArraysThe library synthesis was performed by using the previously de-
For single substrates, the Affymetrix Geneflex array was used forscribed general procedures for PNA oligomerization/deprotection
spatial deconvolution and fluorescence detection. Substrates 2 andand Alloc-protected amino acid coupling/deprotection. The library
4 were diluted to a concentration range of 1–800 pM in CAB, andsynthesis is summarized in Figure 4. Briefly, resin 5 was split into
caspase-3 was added to a final concentration of 100 nM. The sam-three batches, and the first residue was coupled to the rhodamine
ples were incubated overnight at room temperature. The solutionsas described (vide supra) to obtain three pools of resin 15. Consider-
were diluted with a modified PBS buffer, containing 250 mM NaCling the small number of pools in the first step, each of the three
(PBSS).pools was directly split into four pools for introduction of the second
The Affymetrix GenFlex Arrays were hydrated by applying 180 lresidue (14), which is orthogonally protected with an Alloc (the
CHB (Chip Hydration Buffer: 100 mM MES [pH 6.5], 1 M NaCl) toamount of resin was calculated based on the efficiency of the first
the chips, followed by incubation of the chips for 1 hr at 45C in ancoupling). The Mtt was selectively removed, and after appropriate
Affymetrix hybridization oven. The CHB was removed, and the chipscoupling to the polyetnylen spacers and lysine, the respective co-
were washed two times with PBSS. A solution (6 l ) of Affymetrixdons were introduced by reiterative PNA couplings to afford 12
GeneFlex control probes was added to 180 l of the diluted sub-pools of 16. The pools of 16 were combined, the Alloc group was
strate solutions, and the samples were applied to the GenFlex chips.removed, and the resin was redistributed into four pools for third
The samples were hybridized for 4 hr at 45C to the chips, and theresidue coupling and its PNA encoding, thus yielding four pools of
sample solutions were removed. The chips were washed three timesPNA-encoded tripeptide 17. Repeating the same procedure, fol-
with 180 l PBSS and filled with 180 l PBSS. The chips were readlowed by the addition of a last lysine residue to cap the encoding
on an Affymetrix chip reader with the standard argon ion laser asPNA afforded four pools of tetrapeptide 18. The resin was combined
a light source and 530 nm as the detection wavelength. The averageand Alloc deprotected, and the peptide chain was capped with an
intensity of ten randomly picked border probes was used for normal-acetyl group. The library was cleaved from the resin by using a
ization.solution of TFA:m-cresol:H2O (80:19:1) for 1 hr and precipitated in
Et2O. The precipitates were pelleted, washed with Et2O, resus-
pended in 9:1 H2O:MeCN, and lyophilized. Limited Hydrolysis of the 192 Member PNA-Encoded
Protease Substrate Library
The 192 member PNA-encoded library was diluted to a final concen-Enzymatic Activity Monitored with Protease
Substrates 1 and 3 tration of 33 M into 1 ml THB or CAB containing 3% (v/v) DMSO.
Caspase-3, thrombin, and plasmin were used at a final concentrationSubstrates 1 and 3 were used at 250 M. Thrombin was used at a
concentration of 500 pM, and caspase-3 was used at a concentra- of 100, 2.5, and 10 nM, respectively. The mixture was incubated at
room temperature, and the fluorescence was monitored over timetion of 10 nM. For thrombin, a buffer consisting of 50 mM Tris (pH
7.4), 200 mM NaCl, 5 mM CaCl2, and 0.01% (v/v) Tween-20 (THB) was until the desired percentage of hydrolysis (3%–5%) was reached.
The hydrolysis was monitored by fluorescence as described above.used. The buffer for caspase-3 (CAB) consisted of 20 mM HEPES (pH
7.4), 100 mM NaCl, 1mM EDTA, 0.1% CHAPS, 10% (w/v) sucrose, When the desired percentage of hydrolysis was reached, an aliquot
of 200 l was removed, and the enzymatic hydrolysis was quenchedand 10 mM DTT. A total of 50l of the buffer containing the substrate
at a concentration of 500 M was transferred into a well of a black by adding 3 l of a TFA/water (1:5) solution. After the collection of
all samples, the solutions were diluted to a final concentration of96-well Microfluor plate (Dynex Technologies). The reaction was
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2 M of total substrate into PBSS with 3% (v/v) DMSO (50 l final RT), and scanned on an Applied Precision 4500 scanner with the
A488 filter set and an exposure time of 1.0 s. ImaGene 4.2 softwarevolume) and centrifuged (20,000  g, 4C, 20 min).
(BioDiscovery) was used for data analysis.
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